Bio-Techne
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
BAUMGARTNER ROBERT V director
Common Stock 1,885 N/A N/A
Option
BAUMGARTNER ROBERT V director
Common Stock 1,885 N/A N/A
Option
BAUMGARTNER ROBERT V director
Common Stock 2,435 N/A N/A
Sale
OCONNELL HOWARD V director
Common Stock 15,000 N/A N/A
Sale
BAUMGARTNER ROBERT V director
Common Stock 2,435 N/A N/A
Option
OCONNELL HOWARD V director
Stock Option 5,000 N/A N/A
Option
OCONNELL HOWARD V director
Common Stock 10,000 N/A N/A
Option
BAUMGARTNER ROBERT V director
Stock Option 2,435 N/A N/A
Option
OCONNELL HOWARD V director
Stock Option 3,000 N/A N/A
Option
OCONNELL HOWARD V director
Common Stock 3,000 N/A N/A
Sale
OCONNELL HOWARD V director
Common Stock 3,000 N/A N/A
Option
OCONNELL HOWARD V director
Common Stock 10,000 N/A N/A
Option
VERONNEAU MARCEL officer: SVP - Clinical Controls
Common Stock 7,511 N/A N/A
Sale
VERONNEAU MARCEL officer: SVP - Clinical Controls
Common Stock 7,511 N/A N/A
Sale
OCONNELL HOWARD V director
Common Stock 10,000 N/A N/A
Option
VERONNEAU MARCEL officer: SVP - Clinical Controls
Stock Option 7,511 N/A N/A
Option
OCONNELL HOWARD V director
Stock Option 10,000 N/A N/A
Option
VERONNEAU MARCEL officer: SVP - Clinical Controls
Stock Option 7,489 N/A N/A
Option
VERONNEAU MARCEL officer: SVP - Clinical Controls
Common Stock 7,489 N/A N/A
Option
LUCAS ROGER C director
Director Stock Option 10,000 N/A N/A
Sale
LUCAS ROGER C director
Common Stock 10,000 N/A N/A
Option
LUCAS ROGER C director
Common Stock 10,000 N/A N/A
Option
VERONNEAU MARCEL officer: SVP - Clinical Controls
Common Stock 670 N/A N/A
Option
VERONNEAU MARCEL officer: SVP - Clinical Controls
Employee Stock Option 670 N/A N/A
Option
VERONNEAU MARCEL officer: SVP - Clinical Controls
Common Stock 785 N/A N/A
Option
VERONNEAU MARCEL officer: SVP - Clinical Controls
Employee stock option 785 N/A N/A
Purchase
BAUMGARTNER ROBERT V director
Common Stock 500 N/A N/A
Purchase
BAUMGARTNER ROBERT V director
Common Stock 500 N/A N/A
Option
STEER RANDOLPH C director
Common Stock 10,000 N/A N/A
Sale
STEER RANDOLPH C director
Common Stock 10,000 N/A N/A
Option
STEER RANDOLPH C director
Director Stock Option 5,000 N/A N/A
Option
OCONNELL HOWARD V director
Common stock 2,000 N/A N/A
Sale
OCONNELL HOWARD V director
Common Stock 5,000 N/A N/A
Option
OCONNELL HOWARD V director
Common Stock 5,000 N/A N/A
Option
OCONNELL HOWARD V director
Director Stock Option 2,000 N/A N/A
Sale
OCONNELL HOWARD V director
Common Stock 5,000 N/A N/A
Option
VERONNEAU MARCEL officer: SVP - Clinical Controls
Employee stock option 748 N/A N/A
Option
VERONNEAU MARCEL officer: SVP - Clinical Controls
Common Stock 748 N/A N/A
Option
DINARELLO CHARLES A director
Director Stock Option 3,500 N/A N/A
Option
DINARELLO CHARLES A director
Common Stock 3,500 N/A N/A
Sale
DINARELLO CHARLES A director
Common Stock 3,500 N/A N/A
Option
OCONNELL HOWARD V director
Director Stock Option 5,000 N/A N/A
Option
OCONNELL HOWARD V director
Common Stock 5,000 N/A N/A
Sale
OCONNELL HOWARD V director
Common Stock 5,000 N/A N/A
Sale
OCONNELL HOWARD V director
Common Stock 5,000 N/A N/A
Option
OCONNELL HOWARD V director
Common Stock 10,000 N/A N/A
Sale
OCONNELL HOWARD V director
Common Stock 5,000 N/A N/A
Option
OCONNELL HOWARD V director
Director Stock Option 5,000 N/A N/A
Option
OCONNELL HOWARD V director
Common Stock 5,000 N/A N/A
Option
OCONNELL HOWARD V director
Common Stock 5,000 N/A N/A

Showing 500 to 550 of 649 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.